With respect to cancer, here we have demonstrated that miRNA-16 plays a vital role in modulating the G1 cell cycle checkpoint induced by PAD inhibition in p53 WT colon cancer cell lines in vitro. Here, TP53 is linked to malignant colon neoplasm.